Curaleaf Holdings (CURLF) Cash & Equivalents (2019 - 2025)

Curaleaf Holdings' Cash & Equivalents history runs 7 years deep, the most recent figure standing at $101.6 million for Q4 2025.

• In Q4 2025, Cash & Equivalents fell 5.27% year-over-year to $101.6 million; the TTM figure through Dec 2025 stood at $101.6 million (down 5.27% YoY), while the FY2025 annual figure was $101.6 million, down 5.27% from the prior year.
• Cash & Equivalents was $101.6 million for Q4 2025 at Curaleaf Holdings, down from $107.2 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $314.6 million in Q1 2021 to a low of $73.5 million in Q2 2021.
• Historically, Cash & Equivalents has averaged $152.8 million across 5 years, with a median of $101.6 million in 2025.
• The sharpest annual moves came in 2021 and 2023: Cash & Equivalents jumped 643.54% in 2021, then tumbled 71.6% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $73.5 million in 2021, then soared by 307.02% to $299.3 million in 2022, then slumped by 69.33% to $91.8 million in 2023, then rose by 16.78% to $107.2 million in 2024, then dropped by 5.27% to $101.6 million in 2025.
• The last three Cash & Equivalents figures came in at $101.6 million (Q4 2025), $107.2 million (Q4 2024), and $90.0 million (Q3 2024), per Business Quant data.